IL-15 is a critical factor in the development, proliferation and activation of effector natural killer cells and CD8+ T cells [18], [19] and has been listed as the most promising agent among twelve immunotherapy drugs with a high potential for use in treating human cancers [20]. The gene discussed is IL15; the disease is cancer.